We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Awareness Technology, Inc.

Awareness Technology, Inc. provides clinical laboratory instrumentation, reagents and assays for small-to-medium-volu... read more Featured Products: More products

Download Mobile App





Awareness Technology Announces Availability of Two-Plate ELISA and Chemiluminescent Analyzer

By LabMedica International staff writers
Posted on 15 Jun 2020
Awareness Technology, Inc. More...
(Palm City, Florida, USA) has announced the availability of ChemWell 2, its two-probe, two-plate automatic combo analyzer for ELISA and chemiluminescent (CLIA).

Awareness Technology, an international IVD company, develops, manufactures, and markets in-vitro diagnostic instrumentation and diagnostic test kits, including biochemistry, ELISA, chemiluminescence, imaging analytics, electrolyte instruments, and supportive equipment. The company’s test kit portfolio includes ELISA kits for autoimmune and infectious disease testing, biochemistry test kits (for export only), allergy screening products, and instrument QC verification materials.

For 20 years, the company has produced single plate ChemWell automatic ELISA and CLIA systems with the flexibility to run both modes simultaneously even within the same plate. With laboratories expanding serology requirements, the two-plate system is expected to be a more suitable primary instrument for lower throughput labs, and ideal for off-line assays in higher throughput settings.

The key to automating a wide variety of unrelated test methods is ChemWell’s flexibility in both hardware and software. Separate probes are used for samples and reagents with an option for disposable tips. Filters range from 405 nm – 630 nm; dispense volume from 2µL to 1.95 ml; plate washing routines, temperature control, and mixing are programmable. Intuitive software offers on-board pre-dilutions, multiple calibration options, replicates, statistics, QC tracking, bar-coded sample ID and data management. It even schedules assays to prevent timing conflicts while providing optimal throughput. An optional laptop stand conserves bench space.



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.